Psaki Defends FDA Revoking Use Of Antibody Treatments For COVID-19

On Tuesday, White House Press Secretary Jen Psaki defended the FDA abruptly revoking its emergency use authorization for monoclonal antibody treatments for COVID-19. Psaki was asked about the Florida Department of Health announcing in a statement, “Unfortunately, as a result of this abrupt decision made by the federal government, all monoclonal antibody state sites will be closed until further notice.” Psaki responded, “Well, let’s just take a step back here just to realize how crazy this is a little bit.” “We’ve approached COVID treatments like filling a medicine cabinet, we’re not relying on one type, one brand or treatment,” she


